Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrew E. Hendifar"'
Publikováno v:
Immunotherapy. 15:473-476
Autor:
Pamela L. Kunz, Noah T. Graham, Paul J. Catalano, Halla S. Nimeiri, George A. Fisher, Teri A. Longacre, Carlos J. Suarez, Brock A. Martin, James C. Yao, Matthew H. Kulke, Andrew E. Hendifar, James C. Shanks, Manisha H. Shah, Mark M. Zalupski, Edmond L. Schmulbach, Diane L. Reidy-Lagunes, Jonathan R. Strosberg, Peter J. O'Dwyer, Al B. Benson
Publikováno v:
Journal of Clinical Oncology. 41:1359-1369
PURPOSE Patients with advanced pancreatic neuroendocrine tumors (NETs) have few treatment options that yield objective responses. Retrospective and small prospective studies suggest that capecitabine and temozolomide are associated with high response
Publikováno v:
Journal of Gastrointestinal Oncology. 14:1175-1177
Autor:
Camille F, Ng, John, Glaspy, Veronica R, Placencio-Hickok, Shant, Thomassian, Jun, Gong, Arsen, Osipov, Andrew E, Hendifar, Natalie, Moshayedi
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1076-1079
Despite advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains among the deadliest malignancies, with a poor prognosis at time of diagnosis. Research in PDAC has suggested that adaptive signaling in the tumor microenvironmen
Autor:
Nan Wang, Srinivas Gaddam, Yibin Xie, Anthony G. Christodoulou, Chaowei Wu, Sen Ma, Zhaoyang Fan, Lixia Wang, Simon Lo, Andrew E. Hendifar, Stephen J. Pandol, Debiao Li
Publikováno v:
Frontiers in Oncology. 12
Background and aimsAccurate differentiation of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC) is an area of unmet clinical need. In this study, a novel Multitasking dynamic contrast enhanced (DCE) magnetic resonance imaging (MR
Autor:
Eric, Van Cutsem, Margaret A, Tempero, Darren, Sigal, Do-Youn, Oh, Nicola, Fazio, Teresa, Macarulla, Erika, Hitre, Pascal, Hammel, Andrew E, Hendifar, Susan E, Bates, Chung-Pin, Li, Sunil R, Hingorani, Christelle, de la Fouchardiere, Anup, Kasi, Volker, Heinemann, Anthony, Maraveyas, Nathan, Bahary, Laura, Layos, Vaibhav, Sahai, Lei, Zheng, Jill, Lacy, Joon Oh, Park, Fabienne, Portales, Paul, Oberstein, Wilson, Wu, Dimitrios, Chondros, Andrea J, Bullock
Publikováno v:
Scientia
Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
PURPOSE To evaluate the efficacy and safety of pegvorhyaluronidase alfa (PEGPH20) plus nab-paclitaxel/gemcitabine (AG) in patients with hyaluronan-high metastatic pancreatic ductal adenocarcinoma (PDA). PATIENTS AND METHODS HALO 109-301 was a phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa8b97ebf9ba99cec6f3515308b207bd
https://hdl.handle.net/11351/6453
https://hdl.handle.net/11351/6453
Autor:
Alexis Ulrich, Adetunji T. Toriola, Deyali Chatterjee, Maryliza El-Masry, Johanna Nattenmueller, Stacey A. Cohen, Zuri A. Murrell, Mukta Krane, Mika Sinanan, Mary P. Bronner, Afshin E. Gabayan, Jessica N. Cohan, Courtney L. Scaife, Esther Herpel, Laura A. Lambert, Jane C. Figueiredo, Deepti Reddi, Andrew E. Hendifar, William M. Grady, Ulrik Wallin, Jun Gong, Beth A. Moore, Karen Zaghiyan, Lyen C. Huang, Matthew G. Mutch, Caroline Himbert, Cory T. Bernadt, Yosef Y. Nasseri, Matthias Kloor, Erin M. Siegel, Nathan Hinkle, Jolanta Jedrzkiewicz, Cornelia M. Ulrich, Alexandra Gangi, Stephanie L. Schmit, Bartley Pickron, Eiman Firoozmand, Hans-Ulrich Kauczor, Robert W. Decker, Julian Sanchez, Justin Monroe, Christopher I. Li, Martin Schneider, Sophie Dessureault, David Shibata, Biljana Gigic, Kyle G. Cologne, David M. Hoffman, Seth Felder, Sheetal Hardikar
Publikováno v:
Cancer Research. 80:2364-2364
PURPOSE: The ColoCare Study is an international cohort of men and women (>18 years age) newly diagnosed with stage I-IV colorectal cancer from seven centers in the United States and Germany. Study enrollment is currently ongoing. Here, we describe th
Autor:
Georg Lurje, Wu Zhang, Dongyun Yang, Susan Groshen, Andrew E. Hendifar, Hatim Husain, Fumio Nagashima, Heung M. Chang, William Fazzone, Robert D. Ladner, Alexandra Pohl, Yan Ning, Syma Iqbal, Anthony El-Khoueiry, Heinz-Josef Lenz
Publikováno v:
Pharmacogenetics and genomics. 18(2)
Tumor recurrence after curative resection is a major problem in the management of colon cancer therapy. Identifying molecular markers for tumor recurrence is critical for successfully selecting patients who are more likely to benefit from adjuvant ch